Subjects treated with any antithrombotic agents except aspirin. Subject likely to not be available to complete all protocol-required study visits or procedures, to the best of the subject's and investigator's knowledge History or evidence of any other clinically significant disorder, condition, or disease other than those outlined above that, in the opinion of the investigator, may compromise the ability of the subject to give written informed consent, would pose a risk to subject safety or interfere with the study evaluation, procedures, or completion.